SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-20-007210
Filing Date
2020-04-28
Accepted
2020-04-28 12:05:16
Documents
4
Period of Report
2020-04-28
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 345573
2 def14a_001.jpg GRAPHIC 3981
3 image_004.jpg GRAPHIC 237365
4 image_005.jpg GRAPHIC 209035
  Complete submission text file 0001493152-20-007210.txt   967406
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36457 | Film No.: 20823447
SIC: 2834 Pharmaceutical Preparations